Mammen Mathai 4
4 · 10x Genomics, Inc. · Filed May 15, 2023
Insider Transaction Report
Form 4
Mammen Mathai
Director
Transactions
- Sale
Class A Common Stock
2023-05-11$52.82/sh−33,000$1,743,086→ 169,745 total - Exercise/Conversion
Class A Common Stock
2023-05-11$1.16/sh+200,000$232,000→ 202,745 total - Exercise/Conversion
Stock Option (right to buy)
2023-05-11−200,000→ 0 totalExercise: $1.16Exp: 2027-06-12→ Class A Common Stock (200,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $52.43 to $53.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F2]All of the shares subject to the option are fully vested and exercisable as of the date hereof.